Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Radiomics seeks to convert medical images into quantitative biomarkers capable of capturing tumor phenotype, microenvironment, and underlying biology. Over the past fifteen years, the field has expanded beyond handcrafted radiomic features toward deep radiomics, multi-site radiomics, and multi-omics integration, while the need for interpretability has become increasingly central. The aim of this a...
Tyrosine kinase inhibitor (TKI) combined with immunotherapy regimens are now widely used for treating advanced hepatocellular carcinoma (HCC), but their clinical efficacy is limited to a subset of patients. Considering that the vast majority of advanced HCC patients lose the opportunity for liver resection and thus cannot provide tumor tissue samples, we leveraged the clinical and image data to co...
Cellular structural heterogeneity and low intrinsic contrast in label-free bright-field imaging hinder accurate localization of subcellular structures...
OBJECTIVE: To explore the role of multi-sequence magnetic resonance imaging (MRI) images in preoperative prediction of lymph node metastasis in laryng...
The purpose of this study is to explore the potential mechanism of Si-Wu-Tang (SWT) against esophageal squamous cell carcinoma (ESCC). Initially, 18 a...
BACKGROUND:  This study assessed the effectiveness of large language models (LLMs) in generating lay summaries for patient education on the management...
Aflatoxin B1 (AFB1), a known mycotoxin and environmental hazard, has been linked to breast cancer, yet the exact biological pathways remain poorly cha...
BACKGROUND: DNA mutations are the fundamental engines of cancer, driving its initiation and progression. The forces that fuel malignancy are also the ...
Prognostic models in oncology have a profound impact on personalized cancer care and patient profiling, but tend to be heterogeneously developed and i...
Aberrant histone methylation and metabolic alterations are key hallmarks of cancer. Metabolic reprogramming during tumorigenesis could impact the hist...
OBJECTIVES: This retrospective and single-center study aimed to develop machine learning (ML) model integrating clinical features, ultrasound (US) fea...
BACKGROUND: Extrachromosomal circular DNA (eccDNA) is increasingly recognized as a critical driver of oncogene amplification, therapeutic resistance, ...
Fluorescence-guided surgery (FgS) is increasingly used across oncologic specialties to enhance intraoperative visualisation of tumour tissue and lymph...
Artificial intelligence systems are beginning to function as "co-scientists" in cancer research, generating drug candidates, prioritizing immunotherap...
BACKGROUND: Circulating tumor DNA (ctDNA) is sometimes undetectable in liquid comprehensive genomic profiling (CGP) of advanced-stage pancreatic cance...
Cardiotoxicity is a significant challenge in cancer therapies, particularly with doxorubicin, a widely used anthracycline. More predictive in vitro mo...
OBJECTIVES: Female-specific cancers, including breast, ovarian, cervical and uterine malignancies, lack comprehensive early detection approaches, part...
BACKGROUND: Combination immune checkpoint inhibitors are recommended as first-line therapy for advanced hepatocellular carcinoma. However, only a thir...